Mice with Reduced PAR4 Reactivity Show Decreased Venous Thrombosis and Platelet Procoagulant Activity

Overview

Journal bioRxiv

Date 2024 Oct 28

PMID 39463946

Authors

Elizabeth A Knauss

Johana Guci

Norman Luc

Dante Disharoon

Grace H Huang

Anirban Sen Gupta

Marvin T Nieman

Affiliations

Soon will be listed here.

Abstract

Background: Hypercoagulation and thrombin generation are major risk factors for venous thrombosis. Sustained thrombin signaling through PAR4 promotes platelet activation, phosphatidylserine exposure, and subsequent thrombin generation. A single-nucleotide polymorphism in PAR4 (rs2227376) changes proline to leucine extracellular loop 3 (P310L), which decreases PAR4 reactivity and is associated with a lower risk for venous thromboembolism (VTE) in a GWAS meta-analysis.

Objective: The goal of this study is to determine the mechanism for the association of rs2227376 with reduced risk for VTE in using mice with a homologous mutation (PAR4-P322L).

Methods: Venous thrombosis was examined using our recently generated PAR4-P322L mice in the inferior vena cava stasis and stenosis models. Coagulation and clot stability was measured using rotational thromboelastometry (ROTEM). Thrombin generating potential was measured in platelet-rich plasma. Phosphatidylserine surface expression and platelet-neutrophil aggregates were analyzed using flow cytometry.

Results: PAR4 and PAR4 had reduced incidence and size of venous clots at 48 hours. PAR4 and PAR4 platelets had progressively decreased phosphatidylserine in response to thrombin and convulxin, which led to decreased thrombin generation and decreased PAR4-mediated platelet-neutrophil aggregation.

Conclusions: The leucine allele in extracellular loop 3, PAR4-322L leads to fewer procoagulant platelets and decreased endogenous thrombin potential. This decreased ability to generate thrombin offers a mechanism for PAR4's role in VTE highlighting a key role for PAR4 signaling.

References

Qureshi S, Yang L, Manithody C, Rezaie A . Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex. Biochemistry. 2009; 48(22):5034-41. PMC: 2693874. DOI: 10.1021/bi900240g. View

Di Cera E . Thrombin. Mol Aspects Med. 2008; 29(4):203-54. PMC: 2491495. DOI: 10.1016/j.mam.2008.01.001. View

Han X, Knauss E, Fuente M, Li W, Conlon R, LePage D . A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity. J Thromb Haemost. 2024; 22(6):1715-1726. DOI: 10.1016/j.jtha.2024.03.004. View

French S, Thalmann C, Bray P, Macdonald L, Murphy A, Sleeman M . A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant. Blood Adv. 2018; 2(11):1283-1293. PMC: 5998926. DOI: 10.1182/bloodadvances.2017015552. View

Manly D, Boles J, Mackman N . Role of tissue factor in venous thrombosis. Annu Rev Physiol. 2010; 73:515-25. PMC: 3076951. DOI: 10.1146/annurev-physiol-042210-121137. View

Bolliger D, Seeberger M, Tanaka K . Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev. 2011; 26(1):1-13. DOI: 10.1016/j.tmrv.2011.07.005. View

Wang H, Rosendaal F, Cushman M, van Hylckama Vlieg A . D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly. Res Pract Thromb Haemost. 2021; 5(5):e12536. PMC: 8268666. DOI: 10.1002/rth2.12536. View

Payne H, Brill A . Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis. J Vis Exp. 2017; (130). PMC: 5755672. DOI: 10.3791/56697. View

Denorme F, Campbell R . Procoagulant platelets: novel players in thromboinflammation. Am J Physiol Cell Physiol. 2022; 323(4):C951-C958. PMC: 9484986. DOI: 10.1152/ajpcell.00252.2022. View

10.

Merali S, Wang Z, Frost C, Callejo M, Hedrick M, Hui L . New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans. Platelets. 2022; 33(7):969-978. DOI: 10.1080/09537104.2022.2088719. View

11.

Wakefield T, Strieter R, Wilke C, Kadell A, Wrobleski S, Burdick M . Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol. 1995; 15(2):258-68. DOI: 10.1161/01.atv.15.2.258. View

12.

Monroe D, Hoffman M, Roberts H . Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002; 22(9):1381-9. DOI: 10.1161/01.atv.0000031340.68494.34. View

13.

Versteeg H, Heemskerk J, Levi M, Reitsma P . New fundamentals in hemostasis. Physiol Rev. 2013; 93(1):327-58. DOI: 10.1152/physrev.00016.2011. View

14.

Lee R, Kawano T, Grover S, Bharathi V, Martinez D, Cowley D . Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability. J Thromb Haemost. 2021; 20(2):422-433. PMC: 8792346. DOI: 10.1111/jth.15569. View

15.

Edelstein L, Simon L, Lindsay C, Kong X, Teruel-Montoya R, Tourdot B . Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race. Blood. 2014; 124(23):3450-8. PMC: 4246040. DOI: 10.1182/blood-2014-04-572479. View

16.

Kahn M, Shapiro M, Ishihara H, Coughlin S . Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999; 103(6):879-87. PMC: 408153. DOI: 10.1172/JCI6042. View

17.

Engelmann B, Massberg S . Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2012; 13(1):34-45. DOI: 10.1038/nri3345. View

18.

Kulkarni S, Woollard K, Thomas S, Oxley D, Jackson S . Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading. Blood. 2007; 110(6):1879-86. DOI: 10.1182/blood-2006-08-040980. View

19.

Bagot C, Arya R . Virchow and his triad: a question of attribution. Br J Haematol. 2008; 143(2):180-90. DOI: 10.1111/j.1365-2141.2008.07323.x. View

20.

Mackman N . New insights into the mechanisms of venous thrombosis. J Clin Invest. 2012; 122(7):2331-6. PMC: 3386811. DOI: 10.1172/JCI60229. View